We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1xrw

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1xrw" size="450" color="white" frame="true" align="right" spinBox="true" caption="1xrw" /> '''Solution Structure of a Platinum-Acridine Mo...)
Line 1: Line 1:
-
[[Image:1xrw.gif|left|200px]]<br /><applet load="1xrw" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1xrw.gif|left|200px]]<br /><applet load="1xrw" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1xrw" />
caption="1xrw" />
'''Solution Structure of a Platinum-Acridine Modified Octamer'''<br />
'''Solution Structure of a Platinum-Acridine Modified Octamer'''<br />
==Overview==
==Overview==
-
[PtCl(en)(ACRAMTU-S)](NO(3))(2) (PT-ACRAMTU; en = ethane-1,2-diamine, ACRAMTU = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) is a dual, metalating/intercalating DNA binding drug conjugate that shows, cytotoxicity at micromolar to nanomolar concentrations in a wide range of, solid tumor cell lines. In approximately 80% of its adducts, PT-ACRAMTU, binds to guanine-N7 in the major groove, selectively at 5'-CG sites, [Budiman, M. E. et al. (2004) Biochemistry 43, 8560-8567]. Here, we report, the synthesis, physical characterization, and NMR solution structure of a, site-specifically modified octamer containing this adduct, 5'-CCTCGTCC-3'/3'-GGAGCAGG-5', where the asterisk indicates the, [Pt(en)ACRAMTU)](3+) fragment. The structure was determined by a, combination of high-resolution 2-D NMR spectroscopy and restrained, molecular dynamics/molecular mechanics (rMD/MM) calculations using 179 NOE, distance restraints and refined to an r(6) weighted residual (R(x)) of 9.2, x 10(-)(2) using the complete relaxation matrix approach. An average, structure was calculated from the final ensemble of 19 rMD geometries, showing pairwise root-mean-square deviations of &lt;1.05 A. The dual binding, increases the thermal stability of the octamer compared to the unmodified, duplex (DeltaT(m) = 13.2 degrees ). The modified sequence shows structural, features reminiscent of both B- and A-type DNA. Watson-Crick hydrogen, bonding is intact at and beyond the adduct site. Platinum is bound to the, N7 position of G5 in the major groove, and ACRAMTU intercalates into the, central 5'-C4G5/C12G13 base-pair step on the 5'-face of the platinated, nucleobase. The chromophore's long axis is aligned with the long axes of, the adjacent base pairs, maximizing intermolecular pi-pi stacking, interactions. PT-ACRAMTU lengthens (rise, 6.62 A) and unwinds (twist, 15.4, degrees ) the duplex at the central base-pair step but does not cause, helical bending. No C3'-endo deoxyribose pucker and no significant roll, are observed at the site of intercalation/platination, which clearly, distinguishes the PT-ACRAMTU-induced damage from the 1,2-intrastrand, cross-link formed by cisplatin. Overall, the DNA perturbations produced by, PT-ACRAMTU do not appear to mimic those caused by the major cisplatin, lesion. Instead, intriguing structural similarities are observed for, PT-ACRAMTU's monoadduct and the N7 adducts of dual major-groove, alkylating/intercalating antitumor agents, such as the pluramycins.
+
[PtCl(en)(ACRAMTU-S)](NO(3))(2) (PT-ACRAMTU; en = ethane-1,2-diamine, ACRAMTU = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) is a dual metalating/intercalating DNA binding drug conjugate that shows cytotoxicity at micromolar to nanomolar concentrations in a wide range of solid tumor cell lines. In approximately 80% of its adducts, PT-ACRAMTU binds to guanine-N7 in the major groove, selectively at 5'-CG sites [Budiman, M. E. et al. (2004) Biochemistry 43, 8560-8567]. Here, we report the synthesis, physical characterization, and NMR solution structure of a site-specifically modified octamer containing this adduct, 5'-CCTCGTCC-3'/3'-GGAGCAGG-5', where the asterisk indicates the [Pt(en)ACRAMTU)](3+) fragment. The structure was determined by a combination of high-resolution 2-D NMR spectroscopy and restrained molecular dynamics/molecular mechanics (rMD/MM) calculations using 179 NOE distance restraints and refined to an r(6) weighted residual (R(x)) of 9.2 x 10(-)(2) using the complete relaxation matrix approach. An average structure was calculated from the final ensemble of 19 rMD geometries showing pairwise root-mean-square deviations of &lt;1.05 A. The dual binding increases the thermal stability of the octamer compared to the unmodified duplex (DeltaT(m) = 13.2 degrees ). The modified sequence shows structural features reminiscent of both B- and A-type DNA. Watson-Crick hydrogen bonding is intact at and beyond the adduct site. Platinum is bound to the N7 position of G5 in the major groove, and ACRAMTU intercalates into the central 5'-C4G5/C12G13 base-pair step on the 5'-face of the platinated nucleobase. The chromophore's long axis is aligned with the long axes of the adjacent base pairs, maximizing intermolecular pi-pi stacking interactions. PT-ACRAMTU lengthens (rise, 6.62 A) and unwinds (twist, 15.4 degrees ) the duplex at the central base-pair step but does not cause helical bending. No C3'-endo deoxyribose pucker and no significant roll are observed at the site of intercalation/platination, which clearly distinguishes the PT-ACRAMTU-induced damage from the 1,2-intrastrand cross-link formed by cisplatin. Overall, the DNA perturbations produced by PT-ACRAMTU do not appear to mimic those caused by the major cisplatin lesion. Instead, intriguing structural similarities are observed for PT-ACRAMTU's monoadduct and the N7 adducts of dual major-groove alkylating/intercalating antitumor agents, such as the pluramycins.
==About this Structure==
==About this Structure==
-
1XRW is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with 2PT as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1XRW OCA].
+
1XRW is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=2PT:'>2PT</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XRW OCA].
==Reference==
==Reference==
Line 14: Line 14:
[[Category: Baruah, H.]]
[[Category: Baruah, H.]]
[[Category: Bierbach, U.]]
[[Category: Bierbach, U.]]
-
[[Category: Wright, M.W.]]
+
[[Category: Wright, M W.]]
[[Category: 2PT]]
[[Category: 2PT]]
[[Category: acridine]]
[[Category: acridine]]
Line 22: Line 22:
[[Category: unwinding]]
[[Category: unwinding]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 25 02:46:49 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:58:04 2008''

Revision as of 13:58, 21 February 2008


1xrw

Drag the structure with the mouse to rotate

Solution Structure of a Platinum-Acridine Modified Octamer

Overview

[PtCl(en)(ACRAMTU-S)](NO(3))(2) (PT-ACRAMTU; en = ethane-1,2-diamine, ACRAMTU = 1-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) is a dual metalating/intercalating DNA binding drug conjugate that shows cytotoxicity at micromolar to nanomolar concentrations in a wide range of solid tumor cell lines. In approximately 80% of its adducts, PT-ACRAMTU binds to guanine-N7 in the major groove, selectively at 5'-CG sites [Budiman, M. E. et al. (2004) Biochemistry 43, 8560-8567]. Here, we report the synthesis, physical characterization, and NMR solution structure of a site-specifically modified octamer containing this adduct, 5'-CCTCGTCC-3'/3'-GGAGCAGG-5', where the asterisk indicates the [Pt(en)ACRAMTU)](3+) fragment. The structure was determined by a combination of high-resolution 2-D NMR spectroscopy and restrained molecular dynamics/molecular mechanics (rMD/MM) calculations using 179 NOE distance restraints and refined to an r(6) weighted residual (R(x)) of 9.2 x 10(-)(2) using the complete relaxation matrix approach. An average structure was calculated from the final ensemble of 19 rMD geometries showing pairwise root-mean-square deviations of <1.05 A. The dual binding increases the thermal stability of the octamer compared to the unmodified duplex (DeltaT(m) = 13.2 degrees ). The modified sequence shows structural features reminiscent of both B- and A-type DNA. Watson-Crick hydrogen bonding is intact at and beyond the adduct site. Platinum is bound to the N7 position of G5 in the major groove, and ACRAMTU intercalates into the central 5'-C4G5/C12G13 base-pair step on the 5'-face of the platinated nucleobase. The chromophore's long axis is aligned with the long axes of the adjacent base pairs, maximizing intermolecular pi-pi stacking interactions. PT-ACRAMTU lengthens (rise, 6.62 A) and unwinds (twist, 15.4 degrees ) the duplex at the central base-pair step but does not cause helical bending. No C3'-endo deoxyribose pucker and no significant roll are observed at the site of intercalation/platination, which clearly distinguishes the PT-ACRAMTU-induced damage from the 1,2-intrastrand cross-link formed by cisplatin. Overall, the DNA perturbations produced by PT-ACRAMTU do not appear to mimic those caused by the major cisplatin lesion. Instead, intriguing structural similarities are observed for PT-ACRAMTU's monoadduct and the N7 adducts of dual major-groove alkylating/intercalating antitumor agents, such as the pluramycins.

About this Structure

1XRW is a Protein complex structure of sequences from [1] with as ligand. Full crystallographic information is available from OCA.

Reference

Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent., Baruah H, Wright MW, Bierbach U, Biochemistry. 2005 Apr 26;44(16):6059-70. PMID:15835895

Page seeded by OCA on Thu Feb 21 15:58:04 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools